Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Vertex Pharmaceuticals (VRTX)

NASDAQ:VRTX

VRTX

Vertex Pharmaceuticals

RESEARCH TOOLSreports

Vertex Pharmaceuticals (VRTX) Ratios

Compare

6,585 Followers

Vertex Pharmaceuticals Ratios

VRTX's free cash flow for Q3 2025 was $0.87. For the 2025 fiscal year, VRTX's free cash flow was decreased by $ and operating cash flow was $0.42. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	2.36	2.69	3.99	5.22	4.81
Quick Ratio	2.00	2.35	3.78	5.03	4.62
Cash Ratio	1.10	1.28	2.92	4.32	3.63
Solvency Ratio	0.51	-0.05	0.74	0.82	0.74
Operating Cash Flow Ratio	0.83	-0.14	1.00	1.70	1.41
Short-Term Operating Cash Flow Coverage	0.00	-5.34	0.00	0.00	0.00
Net Current Asset Value	$ 3.03B	$ 3.47B	$ 8.99B	$ 9.00B	$ 6.23B
Leverage Ratios
Debt-to-Assets Ratio	0.07	0.08	0.04	0.03	0.04
Debt-to-Equity Ratio	0.11	0.11	0.05	0.04	0.06
Debt-to-Capital Ratio	0.10	0.10	0.04	0.04	0.05
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	1.44	1.37	1.29	1.30	1.33
Debt Service Coverage Ratio	303.68	-2.42	87.19	64.33	41.13
Interest Coverage Ratio	311.98	-7.61	86.89	78.60	45.24
Debt to Market Cap	0.00	<0.01	0.00	0.00	0.00
Interest Debt Per Share	7.23	6.91	3.31	2.40	2.40
Net Debt to EBITDA	-0.67	-5.80	-2.08	-2.17	-2.00
Profitability Margins
Gross Profit Margin	86.28%	86.11%	87.21%	87.90%	88.06%
EBIT Margin	38.06%	2.53%	44.83%	48.01%	36.86%
EBITDA Margin	39.76%	4.41%	46.66%	49.67%	38.52%
Operating Profit Margin	34.06%	-2.11%	38.83%	48.23%	36.73%
Pretax Profit Margin	37.95%	2.25%	44.38%	47.39%	36.05%
Net Profit Margin	31.35%	-4.86%	36.68%	37.20%	30.92%
Continuous Operations Profit Margin	31.35%	-4.86%	36.68%	37.20%	30.92%
Net Income Per EBT	82.61%	-215.53%	82.64%	78.49%	85.78%
EBT Per EBIT	111.40%	-106.70%	114.30%	98.26%	98.14%
Return on Assets (ROA)	14.78%	-2.38%	15.92%	18.30%	17.44%
Return on Equity (ROE)	21.81%	-3.26%	20.59%	23.88%	23.19%
Return on Capital Employed (ROCE)	19.59%	-1.23%	19.98%	27.95%	24.64%
Return on Invested Capital (ROIC)	16.18%	2.63%	16.44%	21.81%	20.99%
Return on Tangible Assets	15.74%	-2.60%	17.40%	20.18%	19.47%
Earnings Yield	3.09%	-0.52%	3.45%	4.49%	4.14%
Efficiency Ratios
Receivables Turnover	6.02	6.85	6.31	6.19	6.66
Payables Turnover	0.40	3.71	3.46	3.55	4.64
Inventory Turnover	0.99	1.27	1.71	2.35	2.56
Fixed Asset Turnover	3.89	4.26	6.79	8.06	6.92
Asset Turnover	0.47	0.49	0.43	0.49	0.56
Working Capital Turnover Ratio	1.89	1.33	0.94	1.03	1.13
Cash Conversion Cycle	-485.53	242.28	165.94	111.89	118.60
Days of Sales Outstanding	60.60	53.31	57.82	58.94	54.78
Days of Inventory Outstanding	369.11	287.47	213.64	155.62	142.54
Days of Payables Outstanding	915.23	98.49	105.52	102.68	78.72
Operating Cycle	429.71	340.77	271.46	214.57	197.32
Cash Flow Ratios
Operating Cash Flow Per Share	14.55	-1.91	13.73	16.13	10.26
Free Cash Flow Per Share	13.06	-3.07	12.72	15.33	9.35
CapEx Per Share	1.49	1.16	1.00	0.80	0.91
Free Cash Flow to Operating Cash Flow	0.90	1.60	0.93	0.95	0.91
Dividend Paid and CapEx Coverage Ratio	9.76	-1.65	13.69	20.18	11.25
Capital Expenditure Coverage Ratio	9.76	-1.65	13.69	20.18	11.25
Operating Cash Flow Coverage Ratio	2.03	-0.28	4.38	7.36	4.75
Operating Cash Flow to Sales Ratio	0.32	-0.04	0.36	0.46	0.35
Free Cash Flow Yield	2.80%	-0.76%	3.13%	5.31%	4.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	32.38	-193.61	28.97	22.26	24.16
Price-to-Sales (P/S) Ratio	10.18	9.41	10.62	8.28	7.47
Price-to-Book (P/B) Ratio	6.87	6.32	5.96	5.32	5.60
Price-to-Free Cash Flow (P/FCF) Ratio	35.77	-131.21	31.98	18.84	23.50
Price-to-Operating Cash Flow Ratio	32.01	-210.51	29.64	17.91	21.41
Price-to-Earnings Growth (PEG) Ratio	24.10	1.69	3.48	0.52	-1.87
Price-to-Fair Value	6.87	6.32	5.96	5.32	5.60
Enterprise Value Multiple	24.95	207.43	20.69	14.43	17.26
Enterprise Value	116.27B	100.88B	95.29B	64.35B	50.76B
EV to EBITDA	24.95	207.43	20.69	14.51	17.40
EV to Sales	9.92	9.15	9.66	7.21	6.70
EV to Free Cash Flow	34.84	-127.64	29.06	16.39	21.08
EV to Operating Cash Flow	31.27	-204.78	26.94	15.58	19.20
Tangible Book Value Per Share	61.82	56.29	60.74	47.72	32.20
Shareholders’ Equity Per Share	67.76	63.73	68.22	54.33	39.19
Tax and Other Ratios
Effective Tax Rate	0.17	3.16	0.17	0.22	0.14
Revenue Per Share	45.87	42.80	38.30	34.87	29.39
Net Income Per Share	14.38	-2.08	14.05	12.97	9.09
Tax Burden	0.83	-2.16	0.83	0.78	0.86
Interest Burden	1.00	0.89	0.99	0.99	0.98
Research & Development to Revenue	0.34	0.33	0.32	0.30	0.40
SG&A to Revenue	0.00	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	0.06	0.06	0.06	0.06	0.06
Income Quality	1.01	0.92	0.98	1.24	1.13

Currency in USD